Logo image of RDZN

ROADZEN INC (RDZN) Stock Fundamental Analysis

NASDAQ:RDZN - VGG7606H1082 - Common Stock

1.01 USD
-0.02 (-1.94%)
Last: 8/25/2025, 1:30:28 PM
Fundamental Rating

1

Taking everything into account, RDZN scores 1 out of 10 in our fundamental rating. RDZN was compared to 282 industry peers in the Software industry. Both the profitability and financial health of RDZN have multiple concerns. RDZN has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RDZN has reported negative net income.
RDZN had a negative operating cash flow in the past year.
In the past 5 years RDZN reported 4 times negative net income.
RDZN had a negative operating cash flow in each of the past 5 years.
RDZN Yearly Net Income VS EBIT VS OCF VS FCFRDZN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

RDZN has a Return On Assets of -86.38%. This is amonst the worse of the industry: RDZN underperforms 89.36% of its industry peers.
Industry RankSector Rank
ROA -86.38%
ROE N/A
ROIC N/A
ROA(3y)-131.55%
ROA(5y)-78.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RDZN Yearly ROA, ROE, ROICRDZN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 2025 0 500 -500 1K

1.3 Margins

With a Gross Margin value of 61.33%, RDZN is not doing good in the industry: 60.64% of the companies in the same industry are doing better.
The Profit Margin and Operating Margin are not available for RDZN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 61.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RDZN Yearly Profit, Operating, Gross MarginsRDZN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 2025 0 50 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

RDZN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RDZN has more shares outstanding
Compared to 1 year ago, RDZN has a worse debt to assets ratio.
RDZN Yearly Shares OutstandingRDZN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 20M 40M 60M
RDZN Yearly Total Debt VS Total AssetsRDZN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 50M 100M 150M 200M

2.2 Solvency

RDZN has an Altman-Z score of -12.02. This is a bad value and indicates that RDZN is not financially healthy and even has some risk of bankruptcy.
RDZN has a worse Altman-Z score (-12.02) than 89.01% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -12.02
ROIC/WACCN/A
WACC11.09%
RDZN Yearly LT Debt VS Equity VS FCFRDZN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 0 50M 100M 150M

2.3 Liquidity

RDZN has a Current Ratio of 0.45. This is a bad value and indicates that RDZN is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.45, RDZN is not doing good in the industry: 91.49% of the companies in the same industry are doing better.
A Quick Ratio of 0.45 indicates that RDZN may have some problems paying its short term obligations.
With a Quick ratio value of 0.45, RDZN is not doing good in the industry: 90.78% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 0.45
Quick Ratio 0.45
RDZN Yearly Current Assets VS Current LiabilitesRDZN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M

More info and screens

4

3. Growth

3.1 Past

RDZN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 80.47%, which is quite impressive.
RDZN shows a decrease in Revenue. In the last year, the revenue decreased by -7.62%.
EPS 1Y (TTM)80.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.96%
Revenue 1Y (TTM)-7.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.66%

3.2 Future

The Earnings Per Share is expected to grow by 44.42% on average over the next years. This is a very strong growth
RDZN is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 51.26% yearly.
EPS Next Y92.39%
EPS Next 2Y44.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year25.58%
Revenue Next 2Y44.55%
Revenue Next 3Y62.37%
Revenue Next 5Y51.26%

3.3 Evolution

RDZN Yearly Revenue VS EstimatesRDZN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
RDZN Yearly EPS VS EstimatesRDZN Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 0 -0.5 -1 -1.5 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RDZN. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 11.00, the valuation of RDZN can be described as very reasonable.
89.01% of the companies in the same industry are more expensive than RDZN, based on the Price/Forward Earnings ratio.
RDZN's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.81.
Industry RankSector Rank
PE N/A
Fwd PE 11
RDZN Price Earnings VS Forward Price EarningsRDZN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RDZN Per share dataRDZN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 0.6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
RDZN's earnings are expected to grow with 44.42% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.42%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

RDZN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROADZEN INC

NASDAQ:RDZN (8/25/2025, 1:30:28 PM)

1.01

-0.02 (-1.94%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-13 2025-08-13/amc
Earnings (Next)N/A N/A
Inst Owners18.74%
Inst Owner Change-34.71%
Ins Owners3.05%
Ins Owner Change0.07%
Market Cap76.78M
Analysts82.5
Price Target4.59 (354.46%)
Short Float %1.43%
Short Ratio0.98
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)49.02%
Min EPS beat(2)1.96%
Max EPS beat(2)96.08%
EPS beat(4)4
Avg EPS beat(4)41.21%
Min EPS beat(4)1.96%
Max EPS beat(4)96.08%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-15.72%
Min Revenue beat(2)-24.8%
Max Revenue beat(2)-6.64%
Revenue beat(4)0
Avg Revenue beat(4)-10.38%
Min Revenue beat(4)-24.8%
Max Revenue beat(4)-2.17%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-18.18%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)5.88%
EPS NY rev (3m)40.74%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-25.44%
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-18.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 11
P/S 1.66
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.41
EYN/A
EPS(NY)0.09
Fwd EY9.09%
FCF(TTM)-0.21
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS0.61
BVpS-0.37
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -86.38%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 61.33%
FCFM N/A
ROA(3y)-131.55%
ROA(5y)-78.97%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover1.4
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.45
Quick Ratio 0.45
Altman-Z -12.02
F-Score5
WACC11.09%
ROIC/WACCN/A
Cap/Depr(3y)31.24%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)80.47%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%92.96%
EPS Next Y92.39%
EPS Next 2Y44.42%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-7.62%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%21.66%
Revenue Next Year25.58%
Revenue Next 2Y44.55%
Revenue Next 3Y62.37%
Revenue Next 5Y51.26%
EBIT growth 1Y68.38%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2415%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2305.78%
OCF growth 3YN/A
OCF growth 5YN/A